124 results
6-K
EX-99.2
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
with Tier 1 capital exceeding $1 billion or with an average rating above investment grade by S&P (LT Local Issuer Credit Rating), Moody’s (Long Term Rating
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
(octreotide capsules) is approved in the US for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment
6-K
EX-99.2
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with injectable octreotide or lanreotide … , please follow this link.
Mycapssa® (octreotide capsules) is approved in the US for long-term maintenance therapy in acromegaly patients who have
6-K
EX-99.3
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
(octreotide capsules) is approved in the US for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment
6-K
EX-99.4
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
in the US for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide
6-K
EX-99.5
s42s0lciimbleajqdps
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.7
smbax50 sahu5qrn8g
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.6
dad3o3u46bx4ho7jl
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
qysvm9ut
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.4
q4wipwt
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.2
k1i85472c w9zxdov
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
c3t4xx1pxhlkmrpq
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.5
9q7ux854ehc69t p0uo
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.1
iq97jat5rsl5v
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.4
lh8nfo2
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.3
qbx53cney8681f
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.2
65dzwzx irzxrc
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.1
d0le blkm
24 Jun 22
Filsuvez® recently approved by the European Commission for the treatment of EB
7:18am
6-K
EX-99.1
mm4 p1tp6ynr
23 Jun 22
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB
7:26am
6-K
EX-99.2
e5kywf9z7z3fczv7v7m
1 Jun 22
Current report (foreign)
6:05am